Mostrar el registro sencillo del ítem
dc.contributor.author | Abanto, Jesús | |
dc.contributor.author | Blanco, D. | |
dc.contributor.author | Saavedra Pastor, Herbert | |
dc.contributor.author | Gonzales, Isidro | |
dc.contributor.author | Siu, Diego | |
dc.contributor.author | Pretell, E. Javier | |
dc.contributor.author | Bustos Palomino, Javier Arturo | |
dc.contributor.author | García Lescano, Héctor Hugo | |
dc.contributor.author | Cysticercosis Working Group in Peru | |
dc.date.accessioned | 2021-10-04T23:00:59Z | |
dc.date.available | 2021-10-04T23:00:59Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/9855 | |
dc.description.abstract | Neurocysticercosis (NCC) is endemic in many parts of the world, carrying significant neurological morbidity that varies according to whether lesions are located inside the cerebral parenchyma or in extraparenchymal spaces. The latter, in particular subarachnoid NCC, is assumed to be more severe, but no controlled studies comparing mortality between types of NCC exist. The aim of this study was to compare all-cause mortality between patients with intraparenchymal NCC and those with subarachnoid NCC. Vital status and sociodemographic characteristics were evaluated in patients with intraparenchymal viable, intraparenchymal calcified, and subarachnoid NCC attending a neurological referral hospital in Lima, Perú. Survival analyses using Kaplan-Meier curves and Cox proportional regression models were carried out to compare mortality rates between groups. From 840 NCC patients followed by a median time of 82.3 months, 42 (5.0%) died, six (1.8%) in the intraparenchymal viable group, four (1.3%) in the calcified group, and 32 (16.6%) in the subarachnoid group (P < 0.001). Older age and lower education were significantly associated with mortality. The age-adjusted hazard ratio for death in the subarachnoid group was 13.6 (95% CI: 5.6-33.0, P < 0.001) compared with the intraparenchymal viable group and 10.7 (95% CI: 3.7-30.8, P < 0.001) when compared with the calcified group. We concluded that subarachnoid disease is associated with a much higher mortality in NCC | en_US |
dc.language.iso | eng | |
dc.publisher | American Society of Tropical Medicine and Hygiene | |
dc.relation.ispartofseries | American Journal of Tropical Medicine and Hygiene (ASTMH Journal) | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | adult | en_US |
dc.subject | age | en_US |
dc.subject | all cause mortality | en_US |
dc.subject | Article | en_US |
dc.subject | calcified parenchymal neurocysticercosis | en_US |
dc.subject | cohort analysis | en_US |
dc.subject | controlled study | en_US |
dc.subject | demography | en_US |
dc.subject | educational status | en_US |
dc.subject | female | en_US |
dc.subject | follow up | en_US |
dc.subject | hazard ratio | en_US |
dc.subject | human | en_US |
dc.subject | Kaplan Meier method | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | mortality rate | en_US |
dc.subject | neurocysticercosis | en_US |
dc.subject | nonhuman | en_US |
dc.subject | Peru | en_US |
dc.subject | proportional hazards model | en_US |
dc.subject | subarachnoid neurocysticercosis | en_US |
dc.subject | survival analysis | en_US |
dc.subject | viable parenchymal neurocysticercosis | en_US |
dc.title | Mortality in parenchymal and subarachnoid neurocysticercosis | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.4269/ajtmh.20-1330 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.06 | |
dc.relation.issn | 1476-1645 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |